- $3B Altos Labs funding scrutinized by Dr. Voss's 'Diaper Test' at Davos.
- BTC drops 0.4% to $75,954 USD; Fear & Greed Index at 27 per CoinGecko.
- Ethereum falls 1.1% to $2,337 USD amid biotech investor caution.
Dr. Elena Voss's 'Diaper Test' at Davos WEF warns immortality tech forces eternal diapers due to bladder decay. Unveiled January 17, 2025. Outrage surges on X. BTC drops 0.4% to $75,954 USD. Fear & Greed Index hits 27, per CoinGecko.
Ethereum falls 1.1% to $2,337 USD. XRP rises 0.2% to $1.44 USD. BNB slides 1.1% to $626.66 USD. USDT stays at $1.00 USD.
- Asset: BTC · Price (USD): 75,954.00 · 24h Change: -0.4%
- Asset: ETH · Price (USD): 2,337.04 · 24h Change: -1.1%
- Asset: XRP · Price (USD): 1.44 · 24h Change: +0.2%
- Asset: BNB · Price (USD): 626.66 · 24h Change: -1.1%
- Asset: USDT · Price (USD): 1.00 · 24h Change: 0.0%
CoinGecko data as of January 20, 2025.
Diaper Test Challenges Transhumanism Core
Dr. Voss stated on her WEF panel: "Extend lifespan without full regeneration, and humans regress to infant-like dependencies." The test targets brain-centric tech like Neuralink's implants, per its science page.
Biotech leaders push forward. Alphabet's Calico Labs pours billions into aging reversal, CEO Hal Barron said in a 2024 STAT interview. Voss flags ignored bodily breakdowns like bladder failure.
AI therapies vow lives spanning millennia. Organ gaps doom basic functions. Investors demand total regeneration now.
Longevity Investments Face Backlash
Altos Labs secured $3 billion USD from Jeff Bezos in 2022, Bloomberg reported. It reprograms cells for youth. Diaper Test exposes risks of partial therapies creating dependency traps.
VC heats up. Biotech drew $12.5 billion USD in 2024, PitchBook Q4 data shows. Voss's critique sparks reviews of incomplete biotech bets.
Crypto links grow. Longevity DAOs on Ethereum pull funds. Fear & Greed at 27 curbs bets, CoinGecko confirms.
Crypto Markets Jitter on Tech Skepticism
Bitcoin's slide mirrors caution. BlackRock's IBIT ETF records small outflows. Ethereum ETFs, greenlit in 2024, face volatility tests.
Solana DeFi sees liquidity dip. XRP steadies post-Ripple SEC victory. BNB drops as Binance Smart Chain biotech tokens stall.
Europe's MiCA rules hike costs for crypto-biotech. ECB eyes fintech-longevity overlaps.
AI and Ethics in Immortality Race
DeepMind models anti-aging proteins. Voss warns of Neuralink chip decay over centuries.
Transhumanists push mind uploads. Bioethicist Dr. Julian Savulescu cautions dystopias, per Oxford Union debates.
a16z VC reins in partial fixes. Crypto factors regulatory risks from immortality hype.
Biotech Pivots to Full Regeneration
Priority shifts to complete solutions. ViaCyte engineers stem cells for organ regrowth. AI slashes trial times 30%, FDA reports confirm.
Crypto tokenizes biotech on Binance Smart Chain. BNB dip flags investor hesitation.
Demands rise for full lifecycle transparency. Ethereum Proof-of-Stake powers efficient rejuvenation AI sims.
Diaper Test pressures accelerate total regen tech. Watch longevity stocks like Unity Biotechnology (UBX), up 2% today. CoinMarketCap monitors crypto-biotech swings.
Frequently Asked Questions
What is the Diaper Test by Dr. Elena Voss?
'Diaper Test' predicts immortality tech causes lifelong diaper dependency from bodily regression. Unveiled at Davos WEF, it critiques partial longevity solutions and ethical gaps.
How does the Diaper Test impact crypto markets?
Fear & Greed Index at 27 per CoinGecko. BTC at $75,954 USD (-0.4%). ETH at $2,337 USD (-1.1%) as tech skepticism spreads.
Why has the Diaper Test caused outrage in longevity tech?
It exposes dystopian risks of extended life without full regeneration. Investors reassess biotech like Altos Labs; AI ethics debates intensify.
What are the tech-finance implications of the Diaper Test?
Crypto DAOs pause funding. Calico and Altos face scrutiny per Bloomberg. Markets shift to full AI-biotech regeneration solutions.
